SerumInstituteIndiaKonto zweryfikowane

@SerumInstIndia

Being the world's third largest vaccine manufacturer, we want to provide affordable yet state-of-the-art life-saving biologicals to people in need globally

Dołączył listopad 2017

Tweety

Zablokowano @SerumInstIndia

Czy na pewno chcesz zobaczyć te Tweety? Zobaczenie Tweetów nie odblokuje @SerumInstIndia

  1. Przypięty tweet
    3 sty
    Cofnij
  2. podał/a dalej
    17 godzin temu

    | The first 10 crore doses of the vaccine have been purchased by the government for a special price of ₹ 200 per dose, Serum Institute CEO Adar Poonawalla told NDTV

    Pokaż ten wątek
    Cofnij
  3. Cofnij
  4. 5 sty

    Important Announcement: Joint statement and

    Cofnij
  5. podał/a dalej
    3 sty

    | I will take the vaccine as soon as 's is officially licensed by DCGI and will share a photo and video, says ,

    Cofnij
  6. podał/a dalej
    3 sty

    'Restricted to export vaccine or sell in pvt mkt under current licence for now,' says CEO in his first interview after DCGI approved the Oxford-AstraZeneca's Covishield vaccine. Adds there is enough stock for govt as well as pvt mkt.

    Cofnij
  7. podał/a dalej
    3 sty
    Cofnij
  8. 3 sty
    Cofnij
  9. podał/a dalej
    28 gru 2020

    Watch Now! Union Minister Dr Harsh Vardhan inaugurates the 7th National Summit on Good, Replicable Practices & Innovations in Public Healthcare Systems via VC.

    Cofnij
  10. 6 gru 2020
    Cofnij
  11. podał/a dalej
    3 gru 2020

    It will be my honour and privilege tonight, to address over a hundred world leaders and nations at the special session on , highlighting India's crucial role and contribution in fighting this unprecedented global pandemic.

    Cofnij
  12. 30 lis 2020

    Addressing concerns related to the adverse event reported by volunteer in Chennai, Serum Institute of India shared; Read Here -

    Cofnij
  13. 28 lis 2020
    Cofnij
  14. podał/a dalej
    23 lis 2020

    I am delighted to hear that, Covishield, a low-cost, logistically manageable & soon to be widely available, vaccine, will offer protection up to 90% in one type of dosage regime and 62% in the other dosage regime. Further details on this, will be provided this evening.

    Cofnij
  15. 19 lis 2020

    Data of the Phase 2 trials of the vaccine in the UK reveals that it appears to produce a strong immune response among older adults and has similar immunogenicity across all groups. Read more here:

    Cofnij
  16. podał/a dalej
    17 lis 2020

    Definition of a good vaccine = 1. Safe 2. Offers long-term protection against targetted disease 3. Can be transported and stored at a manageable temperature 4. Affordable to all of humanity

    Cofnij
  17. 11 lis 2020

    SII has announced the completion of enrolment of Phase III clinical trials for COVISHIELD vaccine in India, under the partnership of Serum Institute of India and Indian Council of Medical Research (ICMR). Read To Know More - 

    Cofnij
  18. podał/a dalej
    10 lis 2020

    Now there are clear reports of the terrible long-term effects of COVID19, so don’t feel you can get it once and that will be the end of it. You can get reinfected in a few months, so please continue taking precautions. Read about the long term effects here

    Cofnij
  19. podał/a dalej
    7 lis 2020

    It gives me great pride representing India at the , on it’s invaluable contribution on how to end this global crisis along with a vaccine that will be widely accessible and affordable. Join me on the 12th of November. Sign up to watch -

    Cofnij
  20. podał/a dalej
    26 paź 2020

    A lot of people were wondering and asking the question, will these early vaccines be effective for the elderly and most vulnerable, here is some preliminary good news.

    Cofnij

Wydaje się, że ładowanie zajmuje dużo czasu.

Twitter jest przeciążony lub wystąpił chwilowy problem. Spróbuj ponownie lub sprawdź status Twittera, aby uzyskać więcej informacji.

    Może Ci się też spodobać

    ·